ARCLK vs SURGY Comparison
Price, market cap, valuation, profitability and leverage metrics of ARCLK and SURGY side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ARCLK | SURGY | Sector median |
|---|---|---|---|
| Last price (TL) | 85.10 | 20.78 | 20.77 |
| Daily change | −0.82% | −4.59% | −4.16% |
| Market cap | TRY 57.5B | TRY 3.5B | TRY 3.7B |
| P/B | 0.75 | 0.34 | 1.17 |
| Dividend yield | 1.71% | — | 1.50% |
| Return on equity | −4.06% | −8.06% | −4.60% |
| Free float | 17.46% | 29.70% | 34.94% |
Popular comparisons
Related pages
About the ARCLK vs SURGY comparison
Price, market cap, valuation multiples, profitability and leverage of ARCLK (Arçelik) and SURGY (Sur Tatil Evleri GMYO) side by side as of Sep 28, 2026, 12:31. Of the 11 metrics compared, ARCLK leads in 6 and SURGY leads in 5.
Highlights: Daily change: ARCLK leads (−0.82% vs −4.59%). Market cap: ARCLK leads (TRY 57.5B vs TRY 3.5B). P/B: SURGY leads (0.34 vs 0.75). EV/Sales: ARCLK leads (0.90 vs 204.54). Gross margin: SURGY leads (47.03% vs 29.57%). EBITDA margin (annual): SURGY leads (2,129.73% vs 14.15%). Net margin (annual): ARCLK leads (−0.60% vs −1,274.66%). Return on assets: ARCLK leads (−0.53% vs −5.70%).
Frequently asked questions
Is ARCLK or SURGY cheaper?
By P/E, Tie is cheaper (— vs —); by P/B, SURGY trades at the lower multiple (0.75 vs 0.34).
Which is more profitable, ARCLK or SURGY?
Annual net margin is −0.60% for ARCLK and −1,274.66% for SURGY; return on equity is −4.06% for ARCLK and −8.06% for SURGY.
Which is more leveraged, ARCLK or SURGY?
The leverage ratio is 86.30 for ARCLK and 30.27 for SURGY; net debt/EBITDA is 2.78 for ARCLK and — for SURGY. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.